Engineering phosphopeptide-decorated magnetic nanoparticles as efficient photothermal agents for solid tumor therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Phototherapy offers high therapeutic efficiency with minimal damage to normal tissues.
• Developing advanced nanomaterials is crucial for effective cancer treatment.

Purpose of the Study:

• To synthesize and evaluate novel phosphopeptide-decorated magnetic nanoparticles (peptide-Fe3O4 nanoparticles) for photothermal therapy.
• To assess the efficacy and biocompatibility of these nanoparticles in treating solid tumors.

Main Methods:

• Synthesis of peptide-Fe3O4 nanoparticles via coprecipitation and ligand exchange.
• Evaluation of photothermal effect upon near-infrared (NIR) light irradiation.
• In vitro biocompatibility assays (cytotoxicity, hemolysis, blood coagulation).
• In vitro and in vivo studies using 4T1 murine breast cancer cells and solid tumors.

Main Results:

• Peptide-Fe3O4 nanoparticles demonstrated a strong photothermal effect and high photo-stability.
• In vitro studies showed low cytotoxicity, negligible hemolysis, and no impact on blood coagulation.
• Effective damage to 4T1 cancer cells and significant solid tumor ablation in animal models were observed.
• Long-term toxicity studies confirmed high biocompatibility.

Conclusions:

• Peptide-Fe3O4 nanoparticles are effective and biocompatible agents for photothermal therapy.
• These nanoparticles show significant potential for solid tumor ablation using NIR light.
• This research opens avenues for developing next-generation photothermal agents in biomedicine.